Atlas Trials

Exploring Occupancy of Dopamine D3 Receptor by Buspirone in Humans Using PET

Clinical trial NCT01699828 · COMPLETED

Trial details

NCT number
NCT01699828
Sponsor
Centre for Addiction and Mental Health
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Smoking CessationTobacco Use Cessation
Start date
2012-10-01
Primary completion
2014-06-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.